UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a leukemia drug be paused? trial tests break from Long-Term treatment
Disease control OngoingThis study is testing whether it's safe and effective to stop taking the drug acalabrutinib after 18 months for older adults with a type of blood cancer called chronic lymphocytic leukemia (CLL). The goal is to see if taking a break from the drug reduces long-term side effects an…
Matched conditions: UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New pill challenges standard chemo for common adult leukemia
Disease control OngoingThis study is comparing a newer, targeted pill called acalabrutinib against a standard combination of chemotherapy and immunotherapy (chlorambucil plus rituximab) for adults with previously untreated chronic lymphocytic leukemia (CLL). It is for older adults or younger adults wit…
Matched conditions: UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC